Entyvio 108 MG/0.68 ML pen 0.68ML
Ended Awarded
- Contract number
- SPE2DB25FSFLR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,506
Award facts
- Contract value 100% obligated
- $29,505.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded September 19, 2025, represents a $29,505.84 firm fixed-price contract for the supply of Entyvio 108 mg/0.68 mL pen injections to be delivered by October 10, 2025. The Defense Logistics Agency (DLA), a subordinate command under the Department of Defense, awarded this non-set-aside competitive contract to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs worldwide.
Entyvio is a biologic medication used primarily in the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn's disease. The delivery order demonstrates AmerisourceBergen's continued role as a critical vendor within the federal medical supply chain, supporting the Defense Health Agency and other military healthcare systems. The firm fixed-price structure and compressed delivery timeline reflect the urgency of pharmaceutical replenishment needs within the military healthcare system, consistent with DLA's strategic approach to maintain stable inventory levels of essential specialty medications across domestic and global military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FSFLR?
SPE2DB25FSFLR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FSFLR worth?
The government has obligated $29,506 on SPE2DB25FSFLR.
Is contract SPE2DB25FSFLR an order under another contract?
Yes. SPE2DB25FSFLR is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSFLR competed?
The extent of competition for SPE2DB25FSFLR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award